Filana Therapeutics Inc FLNA
$0.96 $0.01 (1.48%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
FLNA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Filana Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Filana Therapeutics Inc. Stock Analysis FLNA
United States Health Care Nano Cap Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. The company is headquartered in Austin, Texas and currently employs 17 full-time employees. The company went IPO on 2000-07-14. The firm's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. The company has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.
Filana Therapeutics Inc (FLNA) Chart
Financial Metrics & Statements of Filana Therapeutics Inc (FLNA)
FAQ's for Filana Therapeutics Inc (FLNA)
- As of August 2026, Filana Therapeutics Inc FLNA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Filana Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Filana Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Filana Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Filana Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Filana Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Filana Therapeutics Inc (FLNA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
